Pipeline AstraZeneca prunes asthma, rare disease pipeline, cultivates cancer portfolio pharminent April 30, 2026
Pipeline Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases pharminent April 27, 2026
Pipeline Pfizer culls early PD-L1 asset after series of clinical wins, deals in cancer pharminent April 24, 2026
Pipeline Roche insists amylin obesity drug still valuable for patients who ‘don’t want side effects’ pharminent April 23, 2026
Pipeline Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine pharminent April 21, 2026
Pipeline Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make Headway pharminent April 8, 2026
Business Pipeline How former Acorda CEO Ron Cohen landed at a Parkinson’s cell therapy startup pharminent March 24, 2026
